Historical yearly usage of glycopeptides for animals and humans: the American-European paradox revisited.

@article{Wegener1998HistoricalYU,
  title={Historical yearly usage of glycopeptides for animals and humans: the American-European paradox revisited.},
  author={Henrik Caspar Wegener},
  journal={Antimicrobial agents and chemotherapy},
  year={1998},
  volume={42 11},
  pages={3049}
}
Kirst et al. (5) in their letter on clinical use of vancomycin in the United States and major European countries state that “although it is well recognized that vancomycin resistance is more prevalent in the United States than in Europe, it has not been explained why avoparcin usage fails to correlate with the different epidemiologies of resistance between the two continents; avoparcin was never approved for use in animals in the United States, in contrast to its broad use as a growth-promoting… CONTINUE READING
16 Citations
8 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

References

Publications referenced by this paper.
Showing 1-8 of 8 references

Similar Papers

Loading similar papers…